Moderna, Inc. MRNA shares are trading higher Tuesday after the company announced European Commission marketing authorization for its COVID-19 vaccine, mNEXSPIKE. Moderna stock is showing upward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results